State-of-the-Art Facility and Multidisciplinary Team Approach Expands Care for Children with Complex Congenital Heart Defects
MIS-C stands for multisystem inflammatory syndrome in children. Formerly called pediatric inflammatory multisystem syndrome, or PIMS, it describes a new health condition seen in children who have been infected with novel coronavirus, recovered from it and later have an immune response that results in symptoms of significant levels of inflammation in organ systems. MIS-C is similar in some ways to other inflammatory conditions like Kawasaki disease and toxic shock syndrome. Children who have MIS-C generally did not have obvious symptoms when they were infected with novel coronavirus, like cough, and generally were healthy prior to developing MIS-C.
The University of Chicago Medicine’s Ivan Moskowitz, MD, PhD, and his team are studying why some cells develop into their adult forms more quickly than others, and how issues with that timing can lead to congenital heart disease.
Exercise capacity can be highly predictive of the risk of complications related to CHD, including developing heart failure.